Colorectal cancer (CRC) is a growing burden in adults less than 50-years-old. In 29 2018, the American Cancer Society (ACS) published a guideline update recommending 30 a reduction in the CRC screening start age for average-risk individuals from 50 to 45. 31 Implementing these recommendations would have important implications for public 32 health. However, the approximate number of people impacted by this change-the 33 average-risk population aged 45 to 49-is not well-described in the literature. Here, we 34 provide methodology to conservatively estimate the average-risk and screening-eligible 35 population in the United States, including those who would be impacted by a lowered 36 CRC screening start age. 37
Using multiple data sources, we estimated the current average-risk population by 38 subtracting individuals with symptomatic CRC, with a family history of CRC, and with 39 inflammatory bowel disease (IBD) and hereditary nonpolyposis colorectal cancer 40 (HNPCC) from the total population. Within this population, we estimated the number of 41 Notably, by subtracting all incidence CRC for individuals aged 45-49, we are 79 conservatively assuming that the incidental cancers for all individuals would occur prior 80 to any potential screening. 81
To identify the number of individuals with a family history of CRC, we reviewed 82 the population-based studies included in the meta-analysis by Henrikson et al, 83 published in 2015 [7] . We used two estimates for family history prevalence due to the 84 heterogeneity of outcomes reported in the meta-analysis. For our smaller estimate, we 85 used a conservative definition of family history ("one or more first-degree relatives with 86 CRC") and identified studies with prevalence values from populations that met our 87 definition of family history ( Table 2) . We calculated an overall prevalence by weighing 88
the prevalence values from each study based on population size. ( The complete workflow and population estimate for each analysis subgroup is 119 described in Figure 1 . We removed individuals diagnosed with CRC, without a family 120 history of CRC, and with hereditary cancer syndromes associated with CRC from the 121 total estimated population of the United States. We estimate the total average-risk 122 population to be between 102. 
